Showing results (1941-1950 of 2,093) with videos related to

Sort By:
Pageof 210
Science (New York, N.Y.)|June 11, 2026
A global map for introgressed structural variation and selection in humansPingHsun Hsieh, Natthapon Soisangwan, David S Gordon, et al.
Contemporary Clinical Trials|January 16, 2016
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL)Shari S Bassuk, JoAnn E Manson, I-Min Lee, et al.
Biomarker Research|November 8, 2024
Comparison and combination of mutation and methylation-based urine tests for bladder cancer detectionNaheema S Gordon, Elspeth K McGuigan, Michaela Ondasova, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Demonstration of toxicity to fish and to mammalian cells by Pfiesteria species: comparison of assay methods and strainsJoann M Burkholder, Andrew S Gordon, Peter D Moeller, et al.
Blood|March 21, 2007
Pleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growthHaiming Chen, Melinda S Gordon, Richard A Campbell, et al.
JAMA Network Open|November 5, 2025
Text Messaging and Video Stories to Support Hypertension Self-Management in Black Veterans: A Randomized Clinical TrialSarah L Cutrona, Sarah E McDannold, Kathryn L DeLaughter, et al.
American Journal of Human Genetics|August 20, 2019
Rates of Actionable Genetic Findings in Individuals with Colorectal Cancer or Polyps Ascertained from a Community Medical SettingAdam S Gordon, Elisabeth A Rosenthal, David S Carrell, et al.
Plos One|November 23, 2022
Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohortCeleena Jefferson, Eric Watson, Julia M Certa, et al.
The Cancer Journal From Scientific American|November 1, 1995
Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapyD H Henry, B J Brooks, D C Case, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Safety, pharmacokinetics, and pharmacodynamics of AMG 102, a fully human hepatocyte growth factor-neutralizing monoclonal antibody, in a first-in-human study of patients with advanced solid tumorsMichael S Gordon, Christopher S Sweeney, David S Mendelson, et al.
Pageof 210